Mumbai: NATCO Pharma has filed a lawsuit against Mr Shamnaad Basheer, professor, West Bengal National University of Juri...
Singapore: Global generics firm, Actavis, has opened its regional office in Singapore that will serve as the headquarter...
Bangalore: As a first step to prevent misuse of drugs, which have been banned abroad from being sold freely in the count...
Multinational pharmaceutical company Mylan sued the US Food and Drug Administration (FDA) for approval to sell a generic...
Singapore: Ranbaxy Laboratories, which is already reeling under several regulatory rebukes owing to quality apprehension...
Singapore: The epilepsy therapeutics market value in the Asia-Pacific (APAC) region, Australia, China, India and Japan, ...
Singapore: Pfizer has settled its litigation against Mylan and Mylan Pharmaceuticals relating to Pfizer's patents coveri...
Singapore: Mundipharma has signed an exclusive agreement with the Swiss subsidiary of Horizon Pharma for the commerciali...
Singapore: Aurobindo Pharma has received US FDA approval for Repaglinide tablets, the generic equivalent of Novo Nordisk...
The year 2012 has brought a world of opportunities for Indian biotech companies, with big-wig biotech firms in the West ...
The king of generics, Cipla, has been aggressive in expanding product portfolio and reaching out to international market...
Singapore: HIV drug developer, Gilead Sciences has partnered with Medicines Patent Pool (MPP) to expand access to Gilead...
Bangalore: The Intellectual Property Appellate Board in Chennai, India, has rejected pharma major Bayer's petition seeki...
Singapore: Irish firm, Perrigo, has declined the acquisition offer from Mylan revalued at USD60 per share in cash and 2....
Singapore: The European Commission (EC) is going to fine seven generic drug firms, including India-based Ranbaxy and Den...
Singapore: Regulatory hurdles continue to haunt Impax Laboratories and its experimental drug, Rytary, that treats idiopa...
Singapore: The US FDA provided its final approval to Indian drug maker Lupin to manufacture and market a generic version...
Singapore: India's Aurobindo Pharma has submitted an Abbreviated New Drug Application (ANDA) for dolutegravir 50mg, for ...
